A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of prostate cancer patients whose first scan was negative, according to new research.
A new high-res PET scanner is making its clinical debut at UZ Leuven. The scanner makes it possible to detect earliest signs of brain diseases, years before a patient experiences the first symptoms.
A novel PET imaging framework reveals that bariatric surgery impacts not only body weight, but also the metabolic function of organs. These insights could support more precise treatment monitoring.
A novel portable, point-of-care PET scanner could provide a cost-effective approach for hospitals to perform biopsies, tumor ablations, and other procedures in constrained clinical environments.
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options.
A PSMA PET/CT imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research finds.
A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research.
Beyond "one-size-fits-all": A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according to new research.
At the 38th European Association of Nuclear Medicine (EANM) Congress, held from October 4–8 in Barcelona, United Imaging, a global manufacturer of cutting-edge medical imaging technology, showcases its most advanced AI-powered molecular imaging innovations, the uMI Panvivo family and the uMI Panorama family, and highlights the company’s strong growth and confidence in the European market.
A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor functional recovery after a heart attack, according to new research.
A novel imaging solution, called PSMA PET scanning, can more effectively detect the recurrence of prostate cancer compared to standard methods, and is associated with improved survival outcomes.
GLP-1 receptor agonists are widely prescribed for individuals with diabetes and weight loss. However, these medications may adversely affect the interpretation of cancer imaging, new research finds.
Using PET/CT imaging, researchers discovered that the biological activity of visceral fat may drive the progression of endometrial cancer, offering a novel angle for diagnosis and treatment.
Researchers explored two promising new biomarkers as potential radiotheranostic targets for endometrial cancer. This could help identify patients who are likely to respond to targeted therapeutics.
A new PET imaging technique can accurately detect and monitor Mycobacteroides abscessus lung infections—one of the most difficult-to-diagnose conditions in patients with lung diseases.
United Imaging, a global leader in cutting-edge diagnostic imaging and radiotherapy solutions, proudly unveils two groundbreaking additions to its portfolio — the uMI Panvivo and the uMR Ultra — both newly CE-marked and set to redefine the standards of precision and performance in medical imaging.
United imaging announces the successful installation of their digital PET/CT system uMI 550 at Centre Mèdic Alomar in Barcelona. Equipped with comprehensive cardiac imaging features, its use extends beyond cardiology.
A large new study of more than 40,000 patients finds that a zero coronary artery calcium score continues to be an accurate indicator of a low risk for a coronary heart event even as a person ages.
Nuclear medicine specialists have successfully used the radiopharmaceutical Ga-68-Trivehexin from Trimt to accurately diagnose patients with pulmonary fibrosis and concurrent lung cancer.
